Celularity Inc. (CELU) vs Envoy Medical, Inc. (COCH)
A side-by-side comparison of Celularity Inc. and Envoy Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.76HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
COCH
Envoy Medical, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CELU vs COCH
growth of $100 · dividends reinvested · last 5yCELU -98.3% (-55.8%/yr)COCH -93.3% (-41.8%/yr)COCH compounded faster over this window
CELU COCH
CELU vs COCH: by the numbers
- •COCH is the larger company ($51M vs $51M market cap).
- •Both run net losses; CELU's is the smaller (-375.77% vs -11304.83% net margin).
Metrics side by side
Valuation
| Metric | CELU | COCH |
|---|---|---|
| P/S ratio | 2.68 | 248.03 |
| P/B ratio | N/A | 15.54 |
Profitability
| Metric | CELU | COCH |
|---|---|---|
| Gross margin | 79.62% | -262.66% |
| Operating margin | -230.92% | -9240.66% |
| Net margin | -375.77% | -11304.83% |
| ROE | N/A | -708.48% |
| ROIC | -192.99% | -208.76% |
Growth (annualized)
| Metric | CELU | COCH |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -41.73% |
Frequently asked
- How have CELU and COCH total returns compared?
- Over the past 5 years, CELU delivered -52.57% and COCH delivered -41.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.